New England Biolabs Inc.
Established in the mid 1970s, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR and qPCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics.
New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and ten subsidiaries located in Australia, New Zealand, Canada, China, France, Germany, Japan, Singapore, Korea and the UK. For more information about New England Biolabs visit www.neb.com/about
New England Biolabs GmbH
New England Biolabs GmbH is the NEB service hub for Central Europe.
We are located at the Technology-Park in Frankfurt-Höchst, enabling us to provide customized service beyond everyday experience. The quality of our personalized services, as well as our ability to deliver high quality products with unsurpassed consistency, guarantee our partners a valuable advantage in their research activities.
…This is how the press sees us:
(Company portrait in the independent magazine “Laborjournal” 12/2014 as PDF)
